[Sumatriptan in treatment of migraine and its efficacy and tolerance in self-assessment by patients].
Prusiński
A
A
Kliniki Neurologicznej Akademii Medycznej w Lodzi.
Barliński
J
J
D000328:Adult; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D010358:Patient Participation; D017366:Serotonin Receptor Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D018170:Sumatriptan / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D017366:Serotonin Receptor Agonists; D018170:Sumatriptan